In the field of medical injection molding, product shrinkage is a common defect that affects quality and safety. Shrinkage manifests as local depressions on the product surface, often occurring in areas with abrupt changes in wall thickness (such as the back of reinforcing ribs and supports) or in thick-walled sections. This defect not only mars the product's appearance but may also reduce its structural strength and even lead to the failure of medical device functions. This article provides a systematic analysis from three dimensions: the causative mechanisms, solutions, and practical cases.

I. Causative Mechanisms of Shrinkage Phenomena

1. Interaction between Material Characteristics and Process Parameters

Plastics expand in volume when in a molten state and undergo thermal shrinkage during cooling and solidification (e.g., ABS has a shrinkage rate of 0.5% - 0.7%), phase-change shrinkage (crystalline plastics can have a shrinkage rate of up to 2.0% - 2.5%), and orientation shrinkage. When the holding pressure is insufficient or the holding time is too short, the molten material cannot fully compensate for the shrinkage voids, resulting in the surface sinking inward. For example, the housing of a pacemaker had a holding pressure that was only 60% of the filling pressure, causing a local shrinkage depth of 0.3 mm, which exceeded the tolerance of 0.2 mm.

2. Structural Defects in Mold Design

• Uneven Wall Thickness: When the main wall thickness exceeds 3 mm and the thickness of the reinforcing rib at the root is more than 50% of the main wall thickness, the shrinkage in the thick-walled area is significantly greater than that in the thin-walled area, leading to stress concentration. The drip chamber of an infusion set had a rib thickness of 2.5 mm (main wall thickness of 2 mm), resulting in a shrinkage rate of 1.2% on the back, which far exceeded the design standard of 0.8%.
• Failure of the Gating System: If the gate size is too small (e.g., diameter less than 0.8 mm) or the position is inappropriate (e.g., far from the thick-walled area), the transmission of the holding pressure is blocked. A medical culture dish using a side gate design had a runner length of 80 mm, resulting in a pressure loss of 40%. Shrinkage with a depth of 0.5 mm occurred in the distal area.
• Imbalanced Cooling System: When the spacing between cooling water channels in the thick-walled area is more than 15 mm or the mold temperature control deviation exceeds 5°C, the local shrinkage rate difference can reach 30%. The housing of a blood dialyzer had an uneven mold temperature distribution, with a shrinkage rate difference of 0.4% between the top and bottom, causing overall warping.

3. Systemic Risks in Equipment and Material Management

• Insufficient Plasticizing Capacity: Wear on the screw and barrel reduces the plasticizing volume by 15%, preventing the provision of sufficient molten material to compensate for shrinkage. The components of an insulin injector had an increased shrinkage incidence from 3% to 12% due to insufficient plasticizing volume.
• Batch Differences in Materials: The shrinkage rate of different batches of glass-fiber-reinforced PA66 can vary by 0.2%, causing the out-of-tolerance rate of components for a minimally invasive surgical instrument to increase from 2% to 8%.
• Failure of Environmental Control: When the humidity in the hopper exceeds 0.2%, the hydrolysis degradation of the material for a medical catheter generates gas, forming bubbles with diameters of 0.2 - 0.5 mm and exacerbating the shrinkage risk.

II. Systemic Solutions

1. Optimization of Mold Design

• Wall Thickness Control: Use a gradual sloped transition (slope ≥ 5°) and control the thickness of the reinforcing rib at the root to be 40% - 50% of the main wall thickness. The components of an artificial joint achieved a reduction in shrinkage depth from 0.4 mm to 0.15 mm through optimized rib design.
• Reconstruction of the Gating System: Adopt a hot runner valve gate and implement segmented control of the holding time (3 s of holding for the main gate and a 2 s delay in closing the secondary gate). The lens holder of an endoscope reduced the shrinkage incidence from 25% to 3% through this solution.
• Upgrading of the Cooling System: Use conformal cooling channels (spacing ≤ 8 mm) or beryllium copper inserts (thermal conductivity of 300 W/m·K) in the thick-walled area to control the mold temperature deviation within ±2°C. The components of a surgical robot joint improved the cooling efficiency by 40% and reduced the shrinkage rate by 60% through this improvement.

2. Precise Adjustment of Process Parameters

• Optimization of the Holding Strategy: Implement a combination of high-pressure compensation (90% - 100% of the filling pressure for 2 - 3 s) and low-pressure maintenance (50% - 60% of the filling pressure until the gate solidifies). The housing of a cardiac stent delivery system reduced the shrinkage depth from 0.3 mm to 0.08 mm through this scheme.
• Control of the Temperature Gradient: Increase the melt temperature by 5 - 10°C (e.g., from 230°C to 240°C for ABS) while reducing the mold temperature (reduce the mold temperature in the thick-walled area by 10 - 20°C). The housing of an infusion pump improved the flow front temperature by 15°C and enhanced the holding compensation effect by 30% through this adjustment.
• Segmented Speed Control: Adopt a multi-stage speed curve of "medium-speed filling of the runner → slow filling of the gate → rapid injection → low-speed slow holding". The components of an internal fixation nail improved the weld line strength by 25% and reduced the shrinkage risk by 50% through this scheme.

3. Upgrading of Material and Equipment Management

• Material Modification: Add 3% - 5% nano-calcium carbonate or use 30% glass-fiber-reinforced materials (such as GF-PA66), which can reduce the shrinkage rate by 10% - 15%. The orthopedic implant improved dimensional stability by 40% through material modification.
• Equipment Maintenance: Establish a wear monitoring system for the screw and barrel and replace them when the gap exceeds 0.15 mm. The production line of a dialyzer reduced the fluctuation in plasticizing volume from ±8% to ±2% through this measure.
• Environmental Control: Install a dehumidifying and drying system (dew point ≤ -40°C) in the hopper area to control the material humidity within 0.02%. The production line of catheters reduced the bubble defect rate from 5% to 0.2% through this improvement.

III. Practical Case: Tackling Shrinkage Problems in Minimally Invasive Surgical Instruments

During the trial production of the components for a laparoscopic grasping forceps, a certain enterprise encountered severe shrinkage problems, with a pass rate of only 65%. After analysis, it was found that:

1. Problem Identification: Through mold flow analysis software simulation, it was discovered that the shrinkage rate difference between the thick-walled area (4 mm) and the thin-walled area (1.5 mm) was 0.8%, and the gate froze 1.8 s after the start of holding, preventing effective compensation.
2. Solutions:
   • Mold Modification: Expand the gate diameter from 0.6 mm to 1.0 mm and relocate it to the center of the thick-walled area; add conformal cooling channels to reduce the mold temperature deviation from ±8°C to ±3°C.
   • Process Optimization: Increase the holding pressure from 80 MPa to 100 MPa and extend the holding time from 3 s to 5 s; adjust the melt temperature from 240°C to 245°C and the mold temperature from 60°C to 50°C.
   • Material Upgrade: Replace ordinary PA66 with 30% glass-fiber-reinforced PA66, reducing the shrinkage rate from 0.8% to 0.4%.
3. Implementation Results: The shrinkage depth was reduced from 0.5 mm to less than 0.1 mm, and the pass rate increased to 98%, saving over 2 million yuan in rework costs annually.

FAQ: Quick Answers to Shrinkage Problems in Medical Injection Molding

Q1: How can I quickly determine whether the shrinkage is caused by mold problems or process problems?
A: You can use the "three-step diagnosis method":

1. Check whether the shrinkage occurs in specific areas (shrinkage near a fixed gate is often a process problem, while random distribution is often a mold problem).
2. Measure the ratio of the shrinkage depth to the wall thickness (a ratio greater than 5% often indicates insufficient holding pressure, while a ratio less than 3% often indicates uneven mold cooling).
3. Observe the consistency between trial samples and mass-produced samples (significant differences often indicate equipment or material problems).

Q2: What are the special requirements for controlling the shrinkage of crystalline plastics (such as POM and PA)?
A: The "temperature difference correction method" should be adopted:

1. Make the moving mold temperature 10 - 20°C higher than the fixed mold temperature to use directional shrinkage to counteract warping.
2. Use rapid cooling (mold temperature < 80°C) to inhibit crystallinity and reduce the shrinkage rate.
3. The holding pressure should be 20% - 30% higher than that for non-crystalline plastics to compensate for crystalline shrinkage.

Q3: How can the shrinkage of micro-injection-molded products (such as medical sensors) be solved?
A: The "three key elements of precision control" should be implemented:

1. Equipment: Use a micro-injection molding machine with a screw diameter ≤ 18 mm to ensure an injection volume accuracy of ±0.1%.
2. Mold: Use nano-level polishing (Ra ≤ 0.05 μm) to reduce flow resistance and set up a vacuum exhaust system (residual pressure < 100 Pa).
3. Process: Adopt a strategy of "high-speed high-pressure short shot + low-speed long holding", with an injection speed ≥ 500 mm/s and a holding time ≥ 5 s.